Search

Displaying results 2091 - 2100 of 10000 in total
  1. Drug

    Potassium gluconate

    go.drugbank.com/drugs/DB13620
    Approved

    Potassium gluconate is a salt of [DB01345] and is classified as a food additive by the FDA [L2654]. It is also used as a potassium supplement [L2657]. Potassium is an essential nutrient. … It is the most abundant cation in the intracellular fluid, where it plays a key role in maintaining cell function [A32222].

    Mixtures: Cal-mag Plus K, Mn and Zn CapletsSynonyms: potassium D-gluconate
  2. Drug

    NP-51

    go.drugbank.com/drugs/DB16995
    Investigational

    Synonyms: Bgp-15 free baseSalts: BGP-15
  3. Drug

    Oxybenzone

    go.drugbank.com/drugs/DB01428
    Approved

    It is used as an ingredient in sunscreen and other cosmetics because it absorbs UV-A ultraviolet rays. … Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone. It forms colorless crystals that are readily soluble in most organic solvents.

    Mixtures: Dior Bronze Autobronzant Eclat Du Visage, Cafe au lait Always Stay-on Makeup Broad Spectrum SPF 15 JafraCategories: Compounds used in a research, industrial, or household setting
  4. Drug

    Oxtriphylline

    go.drugbank.com/drugs/DB01303
    Approved

    As such, oxytriphylline is indicated mainly for asthma, bronchospasm, and COPD (i.e. all the same indications as the other theophyllines). … Once in the body, theophylline is released and acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator.

    Synonyms: Teofilinato de colina, Theophyllinate de cholineCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 Substrates
  5. Drug

    Gallamine triethiodide

    go.drugbank.com/drugs/DB00483
    ApprovedWithdrawn

    A synthetic nondepolarizing blocking drug. … It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA Drug Evaluations Annual, 1992, p198)

    Synonyms: Trietioduro de galamina, Triéthiodure de GallamineProducts: Flaxedil Inj 20mg/ml
  6. Drug

    Fotemustine

    go.drugbank.com/drugs/DB04106
    Investigational

    Products: MUPHORAN 208 MG FLAKON, 1 ADET, Muphoran 200 mg/4ml Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
  7. Drug

    Mipomersen

    go.drugbank.com/drugs/DB05528
    Approved

    Mipomersen sodium prevents the formation of apo B-100, resulting in a decrease in the levels of apolipoprotein B (apo B), low density lipoprotein (LDL), and total cholesterol. … Due to this serious risk of liver toxicity, mipomersen sodium is only available to patients under the restricted program called Kynamro Risk Evaluation and Mitigation Strategy program.

    Categories: Apolipoprotein B-100 Synthesis Inhibitor, Compounds used in a research, industrial, or household setting
  8. Drug

    Reviparin

    go.drugbank.com/drugs/DB09259
    Approved

    Reviparin is a low molecular weight heparin which seems to have a better safety profile than unfractionated heparin. … Reviparin has a molecular weight of 3.9 kDa.[A32021] It was developed by Abbott laboratories and in 2009, reviparin presented an orphan drug designation by the FDA.[L1469]

    Products: CLIVARIN 5726 IE A XA/ML, CLIVARODI 17178 A XA/ML
  9. Drug

    Phenprobamate

    go.drugbank.com/drugs/DB13354
    Investigational

    Mixtures: KUILIL 200 MG/200 MG FİLM TABLET, 40 TABLET, KUIFLEX 200 MG/200 MG FİLM KAPLI TABLET, 40 ADETProducts: GAMAFLEX 400 MG FİLM KAPLI TABLET, 40 ADET
  10. Drug

    Lorcaserin

    go.drugbank.com/drugs/DB04871
    ApprovedInvestigationalWithdrawn

    In February 2020, the FDA issued a Drug Safety Communication requesting the manufacturer of Belviq (lorcaserin hydrochloride tablets, 10 mg) and Belviq XR (lorcaserin hydrochloride extended-release tablets … , 20 mg) to voluntarily withdraw these products from the U.S. market, and the company has submitted a request to voluntarily withdraw the drug.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A1 Substrates